Bone Marrow Stem Cells for Chronic Kidney Disease

Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)

Recruiting Observational Study
Chronic Kidney Diseases Kidney Transplant
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
75 (estimated)
Sponsor
Mayo Clinic · Other
Who this trial is looking for

This trial is looking for adults with chronic kidney disease or kidney transplant recipients who have worsening kidney function. Participants will receive infusions of stem cells and will have follow-up visits to monitor their safety and health.

Are You a Good Fit for This Trial?
Rules you out Chronic obstructive pulmonary diseaseHepatitis B or CHIV infectionHistory of blood clotting disorders

You may be able to join if

  • I am over 18 years old
  • I have chronic kidney disease with poor kidney function
  • I can provide informed consent
  • I have diabetes with hemoglobin A1c at or below 9%
  • I have evidence of kidney function loss over the last 6 months

You may not be able to join if

  • I have anemia with hemoglobin below 8.5 g/dL
  • I weigh more than 150 kg or have a BMI over 50
  • I have uncontrolled high blood pressure
  • I need ongoing kidney replacement therapy like dialysis
  • I had a heart problem recently
  • I have an active cancer
  • I am pregnant or could become pregnant and do not agree to use contraception
  • I have an active infection

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The purpose of this protocol is to treat an intermediate-sized population with chronic kidney disease (CKD) including kidney transplant recipients. The protocol uses allogeneic bone marrow-derived mesenchymal stem cells (MSCs). MSC infusion may be delivered 1) intravenous or 2) intravenous plus intra-arterial to both kidneys. Individuals will have subsequent follow up for safety evaluations. Repea…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria * Age \>18 years * Estimated glomerular filtration rate (eGFR) \<60 mL/min/1.73m2 * Hemoglobin A1c ≤9%, if diabetes mellitus present * If kidney transplant recipient, must have eGFR\<60 mL/min/1.73m2 and evidence of progressive kidney function loss over ≥6 months * Ability to giv…
Contacts

Donna K Lawson

507-255-7975

lawson.donna3@mayo.edu

CONTACT

Mayo Clinic Regenerative Nephrology Program

regenerativenephrology@mayo.edu

CONTACT